Federated Hermes, Inc. 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-18 10:25 am Purchase |
2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
FEDERATED HERMES INC. FHI |
4,023,860 19.900% |
148,282 (+3.83%) |
Filing |
| 2023-05-10 09:58 am Purchase |
2023-04-30 | 13G | Regulus Therapeutics Inc. RGLS |
FEDERATED HERMES INC. FHI |
3,875,578 19.900% |
970,752 (+33.42%) |
Filing |
| 2023-02-01 11:43 am Sale |
2022-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
FEDERATED HERMES INC. FHI |
2,904,826 17.250% |
-1 (-0.00%) |
Filing |
| 2022-05-16 2:35 pm Purchase |
2022-04-30 | 13G | Regulus Therapeutics Inc. RGLS |
FEDERATED HERMES INC. FHI |
2,904,827 19.900% |
2,904,827 (New Position) |
Filing |